Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients - Wikidata - awgldk - TriplyDB

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

http://www.wikidata.org/entity/Q28289016

about

An innovative strategy to clone positive modifier genes of defects caused by mtDNA mutations: MRPS18C as suppressor gene of m.3946G>A mutation in MT-ND1 gene.UPregulated single-stranded DNA-binding protein 1 induces cell chemoresistance to cisplatin in lung cancer cell lines.Do the complementarities of electrokinetic and chromatographic procedures represent the "Swiss knife" in proteomic investigation? An overview of the literature in the past decade.Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.

P2860

Q36376828-5860ED1E-F5D1-4CFD-95C1-D8D337EADE46 Q38716073-1DD83F09-8C2A-49D8-B804-366208974D57 Q39107333-85070B8D-7865-4B1A-A510-869781FDA504 Q42701719-1EE5772B-859F-4AFE-91FA-A552276A6869

P2860

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

http://www.wikidata.org/entity/Q28289016

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@ast

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@en

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@nl

type

label

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@ast

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@en

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@nl

prefLabel

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@ast

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@en

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@nl

P1433

Q28289016-7FBB1335-15E5-495F-8769-896B61D59910

P1476

Q28289016-E9844EBA-CCAD-4508-80FF-886C72AC037E

P2093

Q28289016-3417209A-2F76-4379-BC54-98FCF414F9BD

Q28289016-441F062F-DDD5-4180-ADCC-119536C83B85

Q28289016-44E678D2-3F2B-4282-9261-8763D58AF129

Q28289016-455D17B4-B689-482F-8952-8612175E2EE5

Q28289016-610677AB-793E-4645-82F5-5F3A4B6DE204

Q28289016-6A62BC14-C3BB-4F95-A950-49783806DE5C

Q28289016-89BD58D4-BD96-42C4-8CC2-4C3F9A813821

Q28289016-8C19392E-39BF-4AA7-9F40-3BBF4FE98CBB

Q28289016-8C285A23-F9DD-4CDD-A91E-DB69AEB5CB1C

Q28289016-8E76541D-59B2-4478-B98E-56BFE6BAEC64

P2860

Q28289016-03A70005-D1AB-44B5-BADA-AD73B6403EE7

Q28289016-1A4BDF7B-23B8-4BFA-A3E0-6A3F7CF97DBD

Q28289016-1EBBE493-2F85-49D1-9ED3-BB9B760EAF17

Q28289016-1EC2E35D-5FA8-4271-B4D3-8F593C6A7C70

Q28289016-24F44168-BA3B-45DB-8B24-AB16FEAC8021

Q28289016-2B6F4C72-3DB9-451F-897E-3A8FE340E258

Q28289016-2FB276FE-F2FA-4572-9D53-DD4116C76D95

Q28289016-32C32B33-77A8-4BEF-8AA5-E7AA6CBED7AF

Q28289016-403B1413-9F00-4DDF-A067-455C17F1BA56

Q28289016-42E1928C-92EA-4068-8C26-7185F6D8A029

P304

Q28289016-5886CB26-CDFF-4D2E-96F8-9634761303C3

P31

Q28289016-E27FF71B-F594-4A62-90EA-29CA88243A06

P356

Q28289016-D6F3EBA2-C32C-4E6F-9273-E9463DB42C61

P407

Q28289016-984CF8E3-B63B-4D03-80AF-B325F87300EF

P433

Q28289016-DD7ED777-686A-457F-B7D2-CEA9E8D5F833

P478

Q28289016-D698743A-35ED-4281-B4C7-34B3D0E920EE

P577

Q28289016-2C94E015-7BFB-4EE9-BE01-1972DD0E2999

P698

Q28289016-BEF87932-E815-45F3-AF3E-FC53F1413383

P356

P1433

Proteomics - Clinical Applications

P1476

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients

@en

P2093

Aimin Huang

http://www.w3.org/2001/XMLSchema#string

Bin Wang

http://www.w3.org/2001/XMLSchema#string

Chuanzhong Huang

http://www.w3.org/2001/XMLSchema#string

Guangya Wei

http://www.w3.org/2001/XMLSchema#string

Huijing Chen

http://www.w3.org/2001/XMLSchema#string

Jingfeng Liu

http://www.w3.org/2001/XMLSchema#string

Kecan Lin

http://www.w3.org/2001/XMLSchema#string

Qiang Chen

http://www.w3.org/2001/XMLSchema#string

Xuan Tao

http://www.w3.org/2001/XMLSchema#string

Yanbin Wu

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of PPARs in Cancer

Isolation and characterization of a human glutathione S-transferase Ha1 subunit gene

Mitochondrial defects in cancer

Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis

Global cancer statistics, 2002

Ligand specificity and conformational stability of human fatty acid-binding proteins

Alcohol and cancer

Mitochondrial diseases in man and mouse

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

P304

403-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201100103

http://www.w3.org/2001/XMLSchema#string

P407

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23589362

http://www.w3.org/2001/XMLSchema#string